Colorectal Cancer Cells in the Liver : From Micro- To Macrometastatic Disease

Acta Chirurgica Belgica

Volumn , Issue 1, 2000, Pages 7-11

  Topal, B ^a   Penninckx, F ^a   Yap, S H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Colorectal cancer; Liver; Metastatis

Indexed keywords

ANIMAL; CANCER INVASION; CELL TRANSFORMATION; COLON; COLORECTAL TUMOR; HUMAN; IMMUNOLOGY; LIVER TUMOR; METASTASIS; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SURVIVAL; VASCULARIZATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034137157     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. TAYLOR I. Liver metastases from colorectal cancer : lessons from the past and present clinical studies. Br J Surg, 1996, 83 : 456-60.
2. AUGUST D. A., OTTOW R. T., SUGARBAKER P. H. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev, 1984, 3 : 303-24.
3. SUGARBAKER P. H., GIANOLA F. J., DWYER A., NEUMAN N. R. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery, 1987, 102 : 79-87.
4. PENNINCKX F., TOPAL B. Time to liver metastatic recurrence after "curative" surgery for low rectal cancer. Unpublished data.
5. ABULAFI A. M., WILLIAMS N. S. Local recurrence of colorectal cancer : the problem, mechanisms, management and adjuvant therapy. Br J Surg, 1994, 81 : 7-19.
6. HERMANEK P. Colorectal Carcinoma: histopathological diagnosis and staging. In : MORITENSEN N. (ed.). Clin Gastroenterology, Vol. 3, No 3. Balliere Tindall, London. 1989.
7. MOERTEL C. G., FLEMING T. R., MACDONALD J. S. et al. Levamisole and Fluorouracil for adjuvant therapy of resected colon carcinoma. N Eng J Med, 1990, 322 (6) : 352-8.
8. MOERTEL C. G., FLEMING T. R., MACDONALD J. S. et al. Intergroup Study of Fluorouracil plus Levamisole as adjuvant therapy for Stage II/Dukes' B2 colon cancer. J Clin Oncol, 1995, 13 : 2936-43.
9. International Multicentre Pooled Analysis of Colon Cancer Trilas (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet, 1995, 345 : 939-44.
10. RIETHMULLER G., JOHNSON J. P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancer. Curr Opin Immunol, 1992, 4 : 647-55
11. FISHER B., FISHER E. R. Experimental evidence in support of the dormant tumor cell. Science, 1959, 130 : 918-9.
12. FISHER E. R., FISHER B. Experimental study of factors influencing development of hepatic metastases from circulating tumor cells. Acta Cytol, 1965, 9 : 146-9.
13. PANIS Y., RIBEIRO J., CHRÉTIEN Y., NORDLINGER B. Dormant Liver Metastases : an experimental study. Br J Surg, 1992, 79 : 221-3.
14. PURKISS S. F., WILLIAMS N. S. Growth rate and percentage hepatic replacement of colorectal liver metastases. Br J Surg. 1993, 80 : 1036-8.
15. FINILAY I. G., MEEK D., BRUNTON F., MCARDLE C. S. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg, 1988, 75 : 641-4.
16. BELLOCO J. P., MARCELLIN L., CHENARD-NEU M. P. Pathology of hepatic metastases from colorectal adenocarcinomas. In : NORDLINGER B., JAECK D. Treatment of Hepatic Metastases of Colorectal Cancer. Springer, Paris, 1992, pp. 9-22.
17. KERBEL R. S. Significance of tumor-host interactions in cancer growth and metastases. Cancer Metastasis Rev, 1995, 14 : 259-62.
18. O'SULLIVAN G. C., COLLINS J. K., O'BRIFN F. et al. Micrometasyases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology, 1995, 109: 1535-40.
19. LINDEMANN F., SCHLIMOK G., DIRSCHEDL P., WITTE J., RIETHMULLER G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet, 1992, 340 : 685-9.
20. GREENSON J. K., ISENHART C. E., RICE R. et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes'B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49 : Correlation with long-term survival Cancer, 1994, 73 : 563-9.
21. LIEFFFES G. J., CLETON-JANSEN A. M., VAN DE VELDE C. J H. et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med, 1998, 339 : 223-8.
22. FISHER E. R., TURNBULL R. B. The cytological demonstration and significance of tumour cells in the mesenteric blood in patients with colorectal cancer. Surg Gynecol Obstet, 1955, 100 102-7.
23. TURNBULL R. B. Jr, KYLE K., WATSON F. R., SPRATT J. Cancer of the colon : the influence of the no-touch isolation technique on survival rates. Ann Surg, 1967, 166 : 420-7.
24. WIGGERS T., JEEKEL J., ARENDS J. W. et al. No-touch isolation technique in colon cancer : a controlled prospective trial. Br J Surg, 1988, 75 : 409-15.
25. O'SULLIVAN G. C., COLLINS J. K., KELLY J., MORGAN J.. MADDEN M., SHANAHAN F. Micrometastases : marker of metastatic potential or evidence of residual disease ? Gut, 1997, 40 : 512-5.
26. TROJANI M., DE MASCAREL I., BONICHON F., COINDRE J. M., DELSOL G. Micrometastases to axillary lymph nodes from carcinoma of breast : detection by immunohistochemistry and prognostic significance. Br J Cancer, 1987, 55 : 303-6.
27. DIEL I. J., KAUFMANN M., GOERNER R., COSTA S. D., KAUI S., BASTERT G. Detection of tumor cells in bone marrow of patients with primary breast cancer : a prognostic factor for distant metastasis. J Clin Oncol, 1992, 10 : 1534-9.
28. MAEHARA Y., OSHIRO T., ENDO K. et al. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery, 1996, 119 : 397-402.
29. JAUCH K. W., HEISS M. M., GRUETZNER U. et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol, 1996, 14 : 1810-7.
30. IZBICKI J. R., PASSLICK B., HOSCH S. B. et al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer : significance of nodal micrometastasis. J Thor Cardiovasc Surg, 1996, 112 : 623-30.
31. PANTEL K., IZBICKI J., BERNWARD P. et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet, 1996, 347 : 649-53.
32. WOOD D. P., BANKS E. R., HUMPHREYS S., RANGNEKAR V. M. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in hone marrow. J Histochem Cytochem, 1994, 42 : 505-11.
33. DIAMANDIS E. P., YU H. Prostate specific antigen immunoreactivity in the milk of lactating women. Clin Chem. 1994, 410: 204-10.
34. RAJ G. V., MORENO J. G., GOMELLA L. G. Utilization of Polymerase Chain Reaction Technology in the Detection of Solid Tumors. Cancer, 1998, 82 : 1419-42.
35. CHO C. H., RADINSKY R. Biology of Colorectal Cancer & Liver Metastasis. In : CURLEY S. A., M.D. (ed.). Liver Cancer. Anderson Solid Tumor Oncology Series, 1998 : 212-229.
36. O'REILLY M. S., HOLMGREN L., SHING Y. et al. Angiostatin : A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma. Cell, 1994, 79 : 315-28.
37. FOLKMAN J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med, 1995, 1 : 27-31.
38. TARTTER P. I. Prognostic Factors : Transfusion and Splenectomy. In : COHEN A. M., WINAWER S. J. Cancer of the Colon, Rectum, and Anus. New York : McGraw-Hill, Inc., 1995, pp. 249-59.
39. ROSENBERG S. A. Principles of cancer management : Biologic therapy. In : DEVITA V. T., Jr. M.D., HELLMAN S., M.D., ROSENBERG S. A., M.D. Ph.D. Cancer: Principles & Practice of Oncology. Lippincott-Raven Publishers, Philadelphia. Fifth Edition, Chapter 1, 1997, pp. 349-373.
40. BARBERA-GUILLEM E., SMITH I., WEISS L., Cancer-Cell Traffic in the Liver. Growth Kinetics of Cancer Cells after Portal-Vein Delivery. Int J Cancer, 1992, 52 : 974-7.
41. HANNA M. G. Jr, PETERS L. C. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunt to surgery. Cancer, 1978, 42 : 2613-25.
42. HANNA M. G. Jr, BRANDHORST J. S., PETERS E. C. Active specific immunotherapy of residual micrometastasis : An evaluation of sources, doses and ratios of BCG with tumor cells. Cancer Immunol Immunother, 1979, 7 : 165-73.
43. HOOVER H. C. Jr, BRANDHORST J. S., PETERS L. C. et al. Adjuvant active specific immunotherapy for human colorectal cancer : 6.5 year median follow-up of a phase 111 prospectively randomized trial. J Clin Oncol, 1993, 11 : 390-9.
44. HOOVE H. C. Jr, SURDYKE M., DANGEL R. et al. Delayed cutaneous hypersensitivity to autologous tumour cells in colorectal cancer patients immunized with an autologous tumor cell : Bacillus Calmette Guérin Vaccine. Cancer Res, 1984, 44 : 1671-6.
45. TAHAKA H., ZITVOGEL L., STORKUS W. J. et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol , 1995, 154 : 6466-74.